Cite
HARVARD Citation
Lan, T. et al. (2022). Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling. Hepatology. 76 (1), pp. 155-171. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lan, T. et al. (2022). Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling. Hepatology. 76 (1), pp. 155-171. [Online].